HomeCRDF • NASDAQ
Cardiff Oncology Inc
add
$2.75
4.18%
After Hours:(2.18%)+0.060
$2.81
Closed: Apr 4, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 151.00K | -3.21% |
Operating expense | 3.01M | 10.50% |
Net income | -11.79M | -26.24% |
Net profit margin | -7.81K | -30.42% |
Earnings per share | -0.21 | 0.00% |
EBITDA | -12.48M | -21.97% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 91.75M | 22.62% |
Total assets | 97.19M | 19.05% |
Total liabilities | 14.24M | 19.69% |
Total equity | 82.95M | — |
Shares outstanding | 66.52M | — |
Price to book | 2.30 | — |
Return on assets | -39.27% | — |
Return on capital | -46.37% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -11.79M | -26.24% |
Cash from operations | -10.27M | -43.82% |
Cash from investing | 4.51M | -66.74% |
Cash from financing | 44.19M | — |
Net change in cash | 38.43M | 498.44% |
Free cash flow | -7.30M | -78.87% |
Previous close
$2.87
Day range
$2.62 - $2.82
Year range
$2.01 - $6.35
Market cap
182.94M USD
Avg Volume
1.18M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1999
Website
Employees
32
